Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R, Bremnes RM, Cabrera A, Jantus-Lewintre E, Sanmartín E, Blasco A, Del Pozo N, Rosell R, Guijarro R, Galbis J, Sánchez JJ, Camps C.
Sirera R, et al. Among authors: bremnes rm.
J Thorac Oncol. 2011 Feb;6(2):286-90. doi: 10.1097/JTO.0b013e31820189a5.
J Thorac Oncol. 2011.
PMID: 21252717
Free article.